To this end, after ACTL6A expression levels were detected (Fig. 8a), we implanted fresh primary tumor samples resected from GC patients into immunocompromised mice and then injected PBS or the GCLC inhibitor BSO (i.p. injection, 750 mg/kg/day)25,50 to the mice (Fig. 8b). The gene discussed is ACTL6A; the disease is neoplasm.